These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 37552392)

  • 1. Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease.
    Chen X; Li X; Cao B; Chen X; Zhang K; Han F; Kan C; Zhang J; Sun X; Guo Z
    Int Urol Nephrol; 2024 Feb; 56(2):571-582. PubMed ID: 37552392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment.
    Shen S; Zhong H; Zhou X; Li G; Zhang C; Zhu Y; Yang Y
    Pharm Biol; 2024 Dec; 62(1):222-232. PubMed ID: 38357845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis.
    Zhang L; Miao R; Yu T; Wei R; Tian F; Huang Y; Tong X; Zhao L
    Pharmacol Res; 2022 Mar; 177():106111. PubMed ID: 35183713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease.
    Deng L; Shi C; Li R; Zhang Y; Wang X; Cai G; Hong Q; Chen X
    J Ethnopharmacol; 2024 Oct; 333():118424. PubMed ID: 38844252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.
    Wu XQ; Zhao L; Zhao YL; He XY; Zou L; Zhao YY; Li X
    Pharm Biol; 2024 Dec; 62(1):423-435. PubMed ID: 38757785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inflammation in diabetic kidney disease.
    Jung SW; Moon JY
    Korean J Intern Med; 2021 Jul; 36(4):753-766. PubMed ID: 34237822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention.
    Ma X; Ma J; Leng T; Yuan Z; Hu T; Liu Q; Shen T
    Ren Fail; 2023 Dec; 45(1):2146512. PubMed ID: 36762989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on role of direct renin inhibitor in diabetic kidney disease.
    Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
    Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
    Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB
    Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.
    Xu C; Ha X; Yang S; Tian X; Jiang H
    Front Endocrinol (Lausanne); 2023; 14():1232790. PubMed ID: 37859992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
    Barrera-Chimal J; Jaisser F
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():16-31. PubMed ID: 32267077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease.
    Gao Y; Su X; Xue T; Zhang N
    Biomed Pharmacother; 2023 Jul; 163():114598. PubMed ID: 37150034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
    Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
    Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases.
    Huang W; Chen YY; Li ZQ; He FF; Zhang C
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease.
    Liao T; Zhao K; Huang Q; Tang S; Chen K; Xie C; Zhang C; Gan W
    Medicine (Baltimore); 2020 Jul; 99(31):e21137. PubMed ID: 32756091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.
    Mazzieri A; Porcellati F; Timio F; Reboldi G
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in drug discovery for diabetic kidney disease.
    Danta CC; Boa AN; Bhandari S; Sathyapalan T; Xu SZ
    Expert Opin Drug Discov; 2021 Apr; 16(4):447-461. PubMed ID: 33003971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy.
    Wang Y; Zhao H; Wang Q; Zhou X; Lu X; Liu T; Zhan Y; Li P
    J Diabetes Res; 2019; 2019():9030893. PubMed ID: 31828168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potential pathways for traditional Chinese medicine intervention in diabetic kidney disease: macrophage polarization].
    Wang WR; Wang XH; Yan L; Zeng Q; Zhan T; Zhan JY; Li JX; Yu RH
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(15):4044-4053. PubMed ID: 39307756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.